Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study.

By P. Paschka, Guido Marcucci, A. Ruppert, K. Mrózek, Hankui Chen, R. Kittles, T. Vukosavljevic, D. Perrotti, J. Vardiman, A. Carroll and 3 more. Journal of Clinical Oncology, 2006

624 citations recorded by the source corpus.

Subfields: Genetics, Hematology

View Paper: https://www.semanticscholar.org/paper/5038abc0b27e5c1a055fa07baf7c8cb79b28aa53

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. A. Tefferi
2. E. Hellström-Lindberg
3. J. Vardiman
4. D. Arber
5. J. Thiele
6. M. Borowitz
7. R. Brunning
8. M. L. Le Beau

Citations in the corpus

• The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. (2009, background): “2); RPN1-EVI1, or AML (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1.”